0OIR Alk -- Financial Calendar For The 2020 Financial Year
17 Dicembre 2019 - 2:12PM
UK Regulatory
TIDMALK TIDMB
2020 financial calendar for ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF):
Silent period 8 January 2020
Annual report 2019 5 February
2020
Annual General Meeting to be held 11 March 2020
at ALK 4.00 p.m.
Bøge Allé 1
2970 Hørsholm, Denmark
Written requests to have specific business
transacted at the AGM will be included in the
agenda if received by the company on
28 January 2020 at the latest
(may be e-mailed to mailto:investor@alk.net investor@alk.net)
--------------------------------------------------------------
Silent period 8 April 2020
Three-month interim report (Q1) 2020 6 May 2020
Silent period 15 July 2020
Six-month interim report (Q2) 2020 12 August 2020
Silent period 14 October
2020
Nine-month interim report (Q3) 2020 11 November
2020
ALK-Abelló A/S
For further information please contact:
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261
2525
Media: Jeppe Ilkjær, mobile +45 3050 2014
About ALK
ALK is a global specialty pharmaceutical company focused on allergy and
allergic asthma. It markets allergy immunotherapy treatments and other
products and services for people with allergy and allergy doctors.
Headquartered in Hørsholm, Denmark, ALK employs around 2,400 people
worldwide and is listed on Nasdaq Copenhagen. Find more information at
www.alk.net.
Attachment
-- FM_22_19UK_17122019
https://ml-eu.globenewswire.com/Resource/Download/b31d8aea-876f-4e88-8121-253bab090afc
(END) Dow Jones Newswires
December 17, 2019 08:12 ET (13:12 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.